Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 8 | 4 | 455-462
Tytuł artykułu

Social functioning and support of addicts on methadone

Treść / Zawartość
Warianty tytułu
Języki publikacji
The study aimed to determine characteristics of addicts on methadone maintenance therapy (MMT), which are related to the level of social functioning, with emphasis on the role of social support. In a prospective study, opiate addicts (n=150) who were on MMT completed the Pompidou questionnaire, the Social Adaptation Self-evaluation Scale (SASS) and the Multidimensional Scale of Perceived Social Support (MSPSS). Statistical data processing was based on testing the difference between features that best distinguish subgroups of addicts who were dissatisfied, moderately satisfied and satisfied with their social functioning. Opiate addicts up to 30 years of age had a statistically higher score on SASS scale than addicts over 30; addicts who are dissatisfied are mainly unemployed and have average or above-average family/community financial status; opiate addicts who were moderately satisfied with their social functioning were three years or longer on MMT; paradoxically, the highest mean value of score on MSPSS scale dominated among addicts who are dissatisfied with their social functioning. These results indicate that age, employment, financial status, duration of MMT are the characteristics of addicts which are related to the level of social functioning. Social support is most perceived by addicts who are dissatisfied with their social functioning.
Słowa kluczowe

Opis fizyczny
  • [1] Mattick R.P., Breen C., Kimber J., Davoli M., Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database of Systematic Reviews, 2009, 3, CD002209
  • [2] Keen J., Oliver P., Rowse G., Mathers N., Does methadone maintenance treatment based on the new national guidelines work in a primary care setting?, Br J Gen Pract, 2003, 53, 461–467
  • [3] Corsi K.F., Lehman W.K., Booth R.E., The effect of methadone maintenance on positive outcomes for opiate injection drug users, J Subst Abuse Treat, 2009, 37, 120–6[Crossref]
  • [4] Joseph H., Stancliff S., Langrod J., Methadone maintenance treatment (MMT): a review of historical and clinical issues, Mt Sinai J Med, 2000, 67, 347–64
  • [5] Marsch L.A., The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis, Addiction, 1998, 93, 515–32[Crossref]
  • [6] Gunne L.M., Gronbladh L., The Swedish methadone maintenance program: a controlled study. Drug Alcohol Depend, 1981, 7, 249–256[Crossref]
  • [7] Ball J.C., Lange W.R., Myers C.P., Friedman S.R., Reducing the risk of AIDS through methadone maintenance treatment, J Health Soc Behav., 1988, 30, 673–684
  • [8] Poser W., Koc J., Ehrenreich H., Methadone maintenance treatment. Methadone treatment can reduce mortality, BMJ, 1995, 310, 463[Crossref]
  • [9] Padaiga Z., Subata E., Vanagas G., Outpatient methadone maintenance treatment program. QoL and health of opioid-dependent persons in Lithuania, Medicina (Kaunas), 2007, 43, 235–41
  • [10] Maeyer J., Vanderplasschen W., Lammertyn J., Nieuwenhuizen C., Sabbe B., Broekaert E., Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment, Qual Life Res, 2011, 20, 139–150[Crossref]
  • [11] Wiklund I., Assessment of patient-reported outcomes in clinical trials: The example of health-related quality of life, Fundamental and Clinical Pharmacology, 2004, 18, 351–363[Crossref]
  • [12] Millson P.E., Challacombe L., Villeneuve P.J., Strike C.J., Fischer B., Myers T., et al., Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs, European Addiction Research, 2006, 12, 74–82[Crossref]
  • [13] Lofwall M.R., Brooner R.K., Bigelow G.E., Kindbom K., Strain E.C., Characteristics of older opioid maintenance patients, Journal of Substance Abuse Treatment, 2005,28,265–272[Crossref]
  • [14] Deering D.E., Frampton M.A., Horn J., Sellman J.D., Adamson S.J., Potiki T.L., Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire, Drug and Alcohol Review, 2004, 23, 273–280[Crossref]
  • [15] Haug N.A., Sorensen J.L., Lollo N.D., Gruber V.A., Delucchi K.L., Hall S.M., Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial, AIDS Care, 2005, 17, 1022–1029[Crossref]
  • [16] Astals M., Domingo-Salvany A., Buenaventura C.C., Tato J., Vazquez J.M., Martin-Santos R., et al., Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment, Substance Use and Misuse, 2008, 43, 612–632[Crossref]
  • [17] Preau M., Protopopescu C., Spire B., Sobel A., Dellamonica P., Moatti J.P., et al., Health related quality of life among both current and former injection drug users who are HIV-infected, Drug and Alcohol Dependence, 2007, 86, 175–182[Crossref]
  • [18] Maeyer J., Vanderplasschen W., Broekaert E., Exploratory study on drug users’ perspectives on quality of life: More than health-related quality of life?, Social Indicators Research, 2009, 90, 107–126[Crossref]
  • [19] Brands B., Brands J., Methadone Maintenance: A Physician’s Guide to Treatment. Toronto: Addiction Research Foundation, Centre for Addiction and Mental Health, 1998
  • [20] Vuckovic N., Dickov A., Martinovc-Mitrovic S., Budisa D., Drugs and medicine. Novi Sad: Futura; 2009, (in Serbian)
  • [21] Bosc M., Dubini A., Polin V., Development and validation of a social functioning scale, the Social Adaptation Self-Evaluation Scale, Eur Neuropsychopharmacol, 1997, 7, S57–S70[Crossref]
  • [22] Zimet G.D., Dahlem N.W., Zimet S.G., Farley G.K., The multidimensional scale of perceived social support, Journal of Personality Assessment, 1988, 52, 30–41[Crossref]
  • [23] Seivewright N.A., Greenwood J., What is important in drug misuse treatment?, Lancet, 1996, 347, 373–376[Crossref]
  • [24] European Monitoring Centre for Drugs and drug Addiction, Annual report on the state of the drugs problems in the European Union, Office for Official Publications of the European Communities, Luxembourg, 2001
  • [25] Ward J., Hall W., Mattick R.P., Role of maintenance treatment in opioid dependence, Lancet, 1999, 353, 221–226[Crossref]
  • [26] Ogborne A.C., Patient characteristics as predictors of treatment outcome for alcohol and drug abusers, In: Israel Y., Glaser F.B., Kalant H., Popham R.E., Schmidt W., Smart R.G, (Eds.) Research Advances in Alcohol and Drug Abuse, New York, Plenum Press, 1978, 177–366[Crossref]
  • [27] TOPPS-II Interstate Cooperative Study Group, Drug treatment completion and post-discharge employment in the TOPPS-II Interstate Cooperative Study, Journal of Substance Abuse Treatment, 2003, 25, 9–18[Crossref]
  • [28] Magura S., Staines G.L., Blankertz L., Madison E.M., The effectiveness of vocational services for substance users in treatment, Substance Use and Misuse, 2004, 39, 2165–2213[Crossref]
  • [29] Mino A., Page D., Dumont P., Broers B., Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva, Drug and Alcohol Dependence, 1998, 50, 233–239[Crossref]
  • [30] Henry-Edwards S., et al., Clinical Guidelines and Procedures for the Use of Methadone in the Maintenance Treatment of Opioid Dependence, National Drug Strategy, Australian Government Department of Health and Ageing, 2003
  • [31] Van de Velde J.C., Schaap G.E., Land H., Followup at a Dutch addiction hospital and the effectiveness of therapeutic community treatment, Substance Use and Misuse, 1998, 33, 1611–1627[Crossref]
  • [32] Gossop M., Marsden J., Stewart D., Rolfe A., Treatment retention and 1 year outcomes for residential programmes in England, Drug and Alcohol Dependence, 1999, 57, 89–98[Crossref]
  • [33] McMurphy S., Shea J., Switzer J., Turner B., Clinc-based treatment for opoid dependance: A qualitative inquiry, American Journal of Health Behavior, 2006, 30, 544–554[Crossref]
  • [34] Dawson D., Grant B., Stinson F., Chou P., Huang B., Ruan W.J., Recovery from DSM-IV alcohol dependence: United States, 2001–2002, Addiction, 2005,100, 281–292[Crossref]
  • [35] McKellar J., Kelly J., Harris A., Moos R., Pretreatment and during treatment risk factors for dropout among patients with substance use disorders, Journal of Addictive Behaviors, 2006, 31, 450–460[Crossref]
  • [36] Moos R., Moos B., Sixteen-year changes and stable remission among treated and untreated individuals with alcohol use disorders, Drug and Alcohol Dependence, 2005, 80, 337–347[Crossref]
  • [37] Schutte K., Nichols K., Brennan P., Moos R., A tenyear follow-up of older former problem drinkers: Risk of relapse and implications of successfully sustained remission, Journal of Studies on Alcohol, 2003, 64, 367–374
  • [38] Booth B., Russell D., Soucek S., Laughlin P., Social support and alcoholism treatment: An exploratory analysis, American Journal of Alcohol Abuse, 1992, 18, 87–101[Crossref]
  • [39] Broome K., Simpson D., Joe G., The role of social support following short-term inpatient treatment, American Journal of Addictions, 2002, 11, 57–65[Crossref]
  • [40] Cohen S., Lichtenstein E., Partner behaviors that support quitting smoking, Journal of Consulting and Clinical Psychology, 1990, 58, 304–302[Crossref]
  • [41] Goehl L., Nunes E., Quitkin F., Hilton I., Social networks and methadone treatment outcomes: The costs and benefits of social ties, American Journal of Drug and Alcohol Abuse, 1993, 19, 251–262[Crossref]
  • [42] Havassy B., Hall S., Wasserman D., Social support and relapse: Commonalities among alcoholics, opiate users and cigarette smokers, Addictive Behaviors, 1991, 16, 232–246
  • [43] Kidorf M., King V., Neufeld K., Stoller K., Peirce J., Brooner R., Involving significant others in the case of opioid-dependent patients receiving methadone, Journal of Substance Abuse Treatment, 2005, 29, 19–27[Crossref]
  • [44] Wasserman D., Stewart A., Delucchi K., Social support and abstinence from opiates and cocaine during opioid maintenance treatment, Drug and Alcohol Dependence, 2001, 65, 65–75[Crossref]
  • [45] Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M., Drug abuse treatment: a national study of effectiveness, Carey: University of North Carolina Press, 1989
  • [46] Simpson D.D., Sells SB., Effectiveness of treatment for drug abuse: an overview of the DARP research program, Advances in Alcohol and Substance Abuse, 1982, 2, 7–29[Crossref]
  • [47] McGlothlin W.H., Anglin M.D., Long-term follow-up of clients of high- and low-dose methadone programs, Arch Gen Psychiatry, 1981, 38, 1055–63[Crossref]
  • [48] Joe G.W., Simpson D.D., Hubbard R.L., Treatment predictors of tenure in methadone maintenance, J Subst Abuse, 1991, 3, 73–84[Crossref]
  • [49] Magura S., Nwakeze P.C., Demsky S.Y., Pre- and in-treatment predictors of retention in methadone treatment using survival analysis, Addiction, 1998, 93, 51–60[Crossref]
  • [50] Xiao L., Wu Z., Luo W., Wei X., Quality of Life of Outpatients in Methadone Maintenance Treatment Clinics, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010, 53, S116–S120[Crossref]
  • [51] Polunina A.G., Davydov D.M., Kozlov A.A., Brain Disintegration in Heroin Addicts: The Natural Course of the Disease and the Effects of Methadone Treatment, Heroin Addict Relat Clin Probl, 2007, 9, 17–26
  • [52] Magura S., Goldsmith D., Casriel C., Goldstein P.J., Lipton D., The validity of methadone clients’ self-reported drug use, International Journal of Addictions, 1987, 22, 727–749
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.